TREATMENT METHODS FOR CROHN'S DISEASE WITH A SPECIFIC ANTI-IL23 ANTIBODY

MA67019B1Active Publication Date: 2026-06-30JANSSEN BIOTECH INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA67019
Authority / Receiving Office: MA · MA
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2022-10-27
Filing Date: 2022-10-27
Publication Date: 2026-06-30
Estimated Expiration: 2042-10-27

Application Information

Patent Timeline

27 Oct 2022

Priority

27 Oct 2022

Application

MA67019

30 Jun 2026

Publication

MA67019B1

IPC: A61P1/00; A61K39/395; A61P37/06; C07K16/24

CPC: C07K16/244; A61P1/00; A61P37/06; A61K2039/505; A61K2039/54; A61K2039/545

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention relates to a method of treating Crohn's disease in a patient by administering a specific IL-23 antibody, for example, guselkumab, at an initial subcutaneous dose and subsequent subcutaneous doses so that the patient responds to the antibody and so as to meet one or more clinical outcome indicators.

Need to check novelty before this filing date? Find Prior Art